| |
| |
|
| Insider
Information: |
Heffernan Michael Thomas |
| Relationship: |
|
| City: |
Cary |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
115,623 |
|
|
Indirect Shares
|
163,043 |
|
|
| Direct
Value |
$2,169,430 |
|
|
|
Indirect Value
|
$5,584,223 |
|
|
| Total
Shares |
278,666 |
|
|
| Total
Value |
$7,753,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
Director |
2024-05-16 |
45,508 |
2016-04-05 |
163,043 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2017-06-09 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2021-06-02 |
48,586 |
2018-12-12 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director |
2019-05-09 |
6,351 |
2019-05-09 |
0 |
Premium* |
|
|
Biohaven Ltd. |
BHVN |
|
2022-10-03 |
15,178 |
2022-10-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-27 |
4 |
OE |
$16.15 |
$320,012 |
D/D |
19,815 |
31,843 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-27 |
4 |
AS |
$23.63 |
$470,253 |
D/D |
(19,815) |
28,023 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-01-19 |
4 |
AS |
$22.50 |
$450,000 |
D/D |
(20,000) |
538,987 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2018-12-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
0 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
|
– • – |
2022-10-03 |
4 |
OE |
$2.40 |
$72,729 |
D/D |
23,217 |
24,877 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2018-10-15 |
4 |
AS |
$16.53 |
$413,250 |
D/D |
(25,000) |
361,000 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2018-11-15 |
4 |
AS |
$16.53 |
$415,122 |
D/D |
(25,000) |
336,000 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2018-12-17 |
4 |
AS |
$18.12 |
$454,491 |
D/D |
(25,000) |
311,000 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-01-15 |
4 |
AS |
$15.56 |
$389,000 |
D/D |
(25,000) |
286,000 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-02-15 |
4 |
AS |
$14.71 |
$370,224 |
D/D |
(25,000) |
252,362 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-03-15 |
4 |
AS |
$17.17 |
$429,250 |
D/D |
(25,000) |
227,362 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-04-15 |
4 |
AS |
$14.91 |
$377,366 |
D/D |
(25,000) |
202,362 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-05-15 |
4 |
AS |
$12.74 |
$321,042 |
D/D |
(25,000) |
182,069 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-06-17 |
4 |
AS |
$11.31 |
$284,246 |
D/D |
(25,000) |
157,069 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2019-07-15 |
4 |
AS |
$11.26 |
$281,500 |
D/D |
(25,000) |
132,069 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-12 |
4 |
OE |
$14.57 |
$421,334 |
D/D |
27,920 |
55,943 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-12 |
4 |
AS |
$22.01 |
$614,519 |
D/D |
(27,920) |
28,023 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-20 |
4 |
OE |
$16.15 |
$545,192 |
D/D |
33,758 |
61,781 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-20 |
4 |
AS |
$23.08 |
$779,135 |
D/D |
(33,758) |
28,023 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-04-19 |
4 |
AS |
$26.00 |
$1,154,401 |
D/D |
(44,400) |
545,793 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-21 |
4 |
OE |
$16.15 |
$752,590 |
D/D |
46,600 |
74,623 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2022-12-21 |
4 |
AS |
$23.11 |
$1,076,926 |
D/D |
(46,600) |
28,023 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2017-11-15 |
4 |
AS |
$15.53 |
$776,500 |
D/D |
(50,000) |
558,987 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
Director |
– • – |
2021-03-15 |
4 |
AS |
$25.26 |
$1,266,774 |
D/D |
(50,075) |
4,047 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
Chairman, President and CEO |
• • – |
2018-06-12 |
4 |
S |
$25.26 |
$1,340,220 |
D/D |
(53,057) |
388,693 |
0 |
- |
|
82 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
